RESEARCH IN PULMONARY HYPERTENSION

In a recent study analyzing 1,130 patients with PAH who were enrolled in one of the original clinical trials of endothelin receptor antagonists (ERAs), it was found that there were distinct response to treatment between men and women and patients of different race. Read article

Study findings published in the Journal of Perinatology...

Birth weight for gestational age is an important predictor of pulmonary hypertension in premature infants with moderate to severe bronchopulmonary dysplasia. Our findings contribute to the growing evidence supporting fetal mechanisms of later onset pulmonary vascular disease. Read more

Study findings in PubMed.gov...

The serum level of uric acid correlates significantly with patient conditions and prognosis in IPAH. And a higher serum level of uric acid predicts worse conditions and prognosis. Read more

Investigators have uncovered a new clue to the cause of pulmonary arterial hypertension, a progressive and frequently lethal disease that in many cases arises mysteriously. A report published in June 2012 describes findings suggesting that bone marrow-derived endothelial progenitor cells play a role in causing the vascular injury in the lung that underlies the disease.

This study was released by the National Heart, Lung, and Blood Institute (NHLBI) on a list of their top research findings of 2012. Read More

(Doctors Lounge) - Gregory T. Armstrong, MD, of St. Jude Children's Research Hospital in Memphis, Tenn., and colleagues conducted a cross-sectional assessment involving 498 adult survivors of childhood cancer to examine the prevalence of pulmonary hypertension, a late effect of cancer therapy. Read article